Global Mycotoxin Testing Market Size
Mycotoxin testing market was valued at 983.89 million in 2024 is expected to reach the value of USD 1968.53 million by 2034, at a CAGR of 7.9% during the forecast period of 2024 to 2034.
Mycotoxin is the term for the secondary metabolites that molds produce that contaminate plants and crops. Mycotoxin has the potential to infect both people and other animals. The fungus that infects the grains produces these toxic chemical byproducts. Numerous species can produce the same mycotoxins, yet a single species can create different kinds. The naked eye cannot miss the poison. However, the mycotoxin-producing mold is visible to the unaided eye. The mold Aspergillus flavus is the source of mycotoxin; it has a yellowish-green appearance. The spores become a deeper green color as the fungus ages. The Food and Agriculture Organization (FAO) of the United Nations (UN) estimates that about 25% of food generated worldwide are mycotoxins, which are naturally harmful secondary mold metabolites. Over 400 distinct compound classes of mycotoxins are known to exist; of them, 25 are very prevalent because of their occurrence. With the world's population expanding and food consumption rising, focusing on the mycotoxin testing market is imperative.
COVID-19 pandemic's effects on the market
The COVID-19 pandemic started to spread globally in the beginning of 2020; many people have contracted the sickness, and significant nations have issued directives to businesses prohibiting their employees from working and stopping operations. Every company is ready to face the losses brought on by this pandemic. Due to the COVID-19 pandemic epidemic in numerous regions and nations, lockdowns in several countries, the closing of international borders, and delays in cross-border transits, which have caused supply chain obstacles, the mycotoxin testing market is expected to experience a fall in 2020.